The FDA approved Boston Scientific’s Spectra WaveWriter Spinal Cord Stimulator System. 1. The system is the first and only FDA-approved system that simultaneously provides paresthesia-based and ...

Sean Sciara announced on LinkedIn that he has taken on the position of chief commercial officer at Onward Medical.

Please provide your email address to receive an email when new articles are posted on . Patients implanted with a spinal cord simulation system reported less severe pain from baseline to follow up.

Boston Scientific shelled out $533 million to buy up the remaining equity it had in Nalu Medical, a private company that produces a miniaturized neurostimulation implant aimed at treating chronic pain ...